🚀 VC round data is live in beta, check it out!
- Public Comps
- Scholar Rock
Scholar Rock Valuation Multiples
Discover revenue and EBITDA valuation multiples for Scholar Rock and similar public comparables like Alkermes, Gan and Lee, Xenon Pharmaceuticals, TG Therapeutics and more.
Scholar Rock Overview
About Scholar Rock
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.
Founded
2017
HQ

Employees
196
Website
Sectors
Financials (LTM)
EV
$5B
Scholar Rock Financials
Scholar Rock reported last 12-month revenue of $5M and negative EBITDA of ($379M).
In the same LTM period, Scholar Rock generated $5M in gross profit, ($379M) in EBITDA losses, and had net loss of ($376M).
Revenue (LTM)
Scholar Rock P&L
In the most recent fiscal year, Scholar Rock reported revenue of — and EBITDA of ($369M).
Scholar Rock expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $5M | XXX | — | XXX | XXX | XXX |
| Gross Profit | $5M | XXX | — | XXX | XXX | XXX |
| Gross Margin | 86% | XXX | — | XXX | XXX | XXX |
| EBITDA | ($379M) | XXX | ($369M) | XXX | XXX | XXX |
| EBITDA Margin | (7213%) | XXX | — | XXX | XXX | XXX |
| EBIT Margin | (7376%) | XXX | — | XXX | XXX | XXX |
| Net Profit | ($376M) | XXX | ($378M) | XXX | XXX | XXX |
| Net Margin | (7162%) | XXX | — | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Scholar Rock Stock Performance
Scholar Rock has current market cap of $6B, and enterprise value of $5B.
Market Cap Evolution
Scholar Rock's stock price is $49.96.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5B | $6B | 0.1% | XXX | XXX | XXX | $-3.29 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialScholar Rock Valuation Multiples
Scholar Rock trades at 1043.0x EV/Revenue multiple, and (14.5x) EV/EBITDA.
EV / Revenue (LTM)
Scholar Rock Financial Valuation Multiples
As of April 19, 2026, Scholar Rock has market cap of $6B and EV of $5B.
Equity research analysts estimate Scholar Rock's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Scholar Rock has a P/E ratio of (15.3x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $6B | XXX | $6B | XXX | XXX | XXX |
| EV (current) | $5B | XXX | $5B | XXX | XXX | XXX |
| EV/Revenue | 1043.0x | XXX | — | XXX | XXX | XXX |
| EV/EBITDA | (14.5x) | XXX | (14.8x) | XXX | XXX | XXX |
| EV/EBIT | (14.1x) | XXX | (14.2x) | XXX | XXX | XXX |
| EV/Gross Profit | 1216.9x | XXX | — | XXX | XXX | XXX |
| P/E | (15.3x) | XXX | (15.2x) | XXX | XXX | XXX |
| EV/FCF | (18.3x) | XXX | (18.2x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Scholar Rock Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Scholar Rock Margins & Growth Rates
Scholar Rock's revenue in the last 12 month grew by 1091%.
Scholar Rock's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $2.0M for the same period.
Scholar Rock Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 1091% | XXX | — | XXX | XXX | XXX |
| EBITDA Margin | (7213%) | XXX | — | XXX | XXX | XXX |
| EBITDA Growth | (11%) | XXX | (0%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $2.0M | XXX | XXX | XXX |
| G&A Expenses to Revenue | 3423% | XXX | — | XXX | XXX | XXX |
| R&D Expenses to Revenue | 3961% | XXX | — | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Scholar Rock Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Scholar Rock | XXX | XXX | XXX | XXX | XXX | XXX |
| Alkermes | XXX | XXX | XXX | XXX | XXX | XXX |
| Gan and Lee | XXX | XXX | XXX | XXX | XXX | XXX |
| Xenon Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| TG Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Henlius Biotech | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Scholar Rock M&A Activity
Scholar Rock acquired XXX companies to date.
Last acquisition by Scholar Rock was on XXXXXXXX, XXXXX. Scholar Rock acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Scholar Rock
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialScholar Rock Investment Activity
Scholar Rock invested in XXX companies to date.
Scholar Rock made its latest investment on XXXXXXXX, XXXXX. Scholar Rock invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Scholar Rock
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Scholar Rock
| When was Scholar Rock founded? | Scholar Rock was founded in 2017. |
| Where is Scholar Rock headquartered? | Scholar Rock is headquartered in United States. |
| How many employees does Scholar Rock have? | As of today, Scholar Rock has over 196 employees. |
| Who is the CEO of Scholar Rock? | Scholar Rock's CEO is David L. Hallal. |
| Is Scholar Rock publicly listed? | Yes, Scholar Rock is a public company listed on Nasdaq. |
| What is the stock symbol of Scholar Rock? | Scholar Rock trades under SRRK ticker. |
| When did Scholar Rock go public? | Scholar Rock went public in 2018. |
| Who are competitors of Scholar Rock? | Scholar Rock main competitors are Alkermes, Gan and Lee, Xenon Pharmaceuticals, TG Therapeutics. |
| What is the current market cap of Scholar Rock? | Scholar Rock's current market cap is $6B. |
| What is the current revenue of Scholar Rock? | Scholar Rock's last 12 months revenue is $5M. |
| What is the current revenue growth of Scholar Rock? | Scholar Rock revenue growth (NTM/LTM) is 1091%. |
| What is the current EV/Revenue multiple of Scholar Rock? | Current revenue multiple of Scholar Rock is 1043.0x. |
| Is Scholar Rock profitable? | No, Scholar Rock is not profitable. |
| What is the current EBITDA of Scholar Rock? | Scholar Rock has negative EBITDA and is not profitable. |
| What is Scholar Rock's EBITDA margin? | Scholar Rock's last 12 months EBITDA margin is (7213%). |
| What is the current EV/EBITDA multiple of Scholar Rock? | Current EBITDA multiple of Scholar Rock is (14.5x). |
| What is the current FCF of Scholar Rock? | Scholar Rock's last 12 months FCF is ($300M). |
| What is Scholar Rock's FCF margin? | Scholar Rock's last 12 months FCF margin is (5711%). |
| What is the current EV/FCF multiple of Scholar Rock? | Current FCF multiple of Scholar Rock is (18.3x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.